| Wayne Fleischhacker, DO | |
|
695 Chestnut Street, Union, NJ 07083 | |
| (908) 851-8602 | |
| (908) 851-8758 |
| Full Name | Wayne Fleischhacker |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 34 Years |
| Location | 695 Chestnut Street, Union, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386637270 | NPI | - | NPPES |
| 6408907 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0000X | Pain Medicine - Pain Medicine | 25MB05848900 (New Jersey) | Secondary |
| 207LP2900X | Anesthesiology - Pain Medicine | 25MB058448900 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Union Anesthesia Associates, Pa | 4082609003 | 11 |
News Archive
All humans are 99.9 percent identical, genetically speaking. But that tiny 0.1 percent variation has big consequences, influencing the color of your eyes, the span of your hips, your risk of getting sick and in some ways even your earning potential.
With an estimated four to six percent of children in the U.S. suffering from food allergies, a new study shows that pediatricians and family physicians aren't always confident they have the ability to diagnose or treat food allergies.
A new study published in the July 11 issue of the Journal of Neuroscience details the development of the first mouse model engineered to carry the most common mutation in Usher syndrome III causative gene (Clarin-1) in North America.
Mazor Robotics Ltd., a leading developer of innovative bone mounted surgical robotic guidance systems, today entered into two strategic agreements with Medtronic plc (NYSE: MDT). One agreement is a two-stage, multi-faceted, commercial agreement for co-promotion, co-development and, upon meeting certain milestones, potential global distribution of certain Mazor products. The second agreement is for an equity investment by Medtronic in Mazor.
Deep brain stimulation has been used to treat Parkinson's disease symptoms for 25 years, but limitations have led researchers to look for ways to improve the technique.
› Verified 5 days ago
| Entity Name | Union Anesthesia Associates, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730293598 PECOS PAC ID: 4082609003 Enrollment ID: O20040419001138 |
News Archive
All humans are 99.9 percent identical, genetically speaking. But that tiny 0.1 percent variation has big consequences, influencing the color of your eyes, the span of your hips, your risk of getting sick and in some ways even your earning potential.
With an estimated four to six percent of children in the U.S. suffering from food allergies, a new study shows that pediatricians and family physicians aren't always confident they have the ability to diagnose or treat food allergies.
A new study published in the July 11 issue of the Journal of Neuroscience details the development of the first mouse model engineered to carry the most common mutation in Usher syndrome III causative gene (Clarin-1) in North America.
Mazor Robotics Ltd., a leading developer of innovative bone mounted surgical robotic guidance systems, today entered into two strategic agreements with Medtronic plc (NYSE: MDT). One agreement is a two-stage, multi-faceted, commercial agreement for co-promotion, co-development and, upon meeting certain milestones, potential global distribution of certain Mazor products. The second agreement is for an equity investment by Medtronic in Mazor.
Deep brain stimulation has been used to treat Parkinson's disease symptoms for 25 years, but limitations have led researchers to look for ways to improve the technique.
› Verified 5 days ago
| Entity Name | Raritan Anesthesia Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083881767 PECOS PAC ID: 1254497621 Enrollment ID: O20090310000350 |
News Archive
All humans are 99.9 percent identical, genetically speaking. But that tiny 0.1 percent variation has big consequences, influencing the color of your eyes, the span of your hips, your risk of getting sick and in some ways even your earning potential.
With an estimated four to six percent of children in the U.S. suffering from food allergies, a new study shows that pediatricians and family physicians aren't always confident they have the ability to diagnose or treat food allergies.
A new study published in the July 11 issue of the Journal of Neuroscience details the development of the first mouse model engineered to carry the most common mutation in Usher syndrome III causative gene (Clarin-1) in North America.
Mazor Robotics Ltd., a leading developer of innovative bone mounted surgical robotic guidance systems, today entered into two strategic agreements with Medtronic plc (NYSE: MDT). One agreement is a two-stage, multi-faceted, commercial agreement for co-promotion, co-development and, upon meeting certain milestones, potential global distribution of certain Mazor products. The second agreement is for an equity investment by Medtronic in Mazor.
Deep brain stimulation has been used to treat Parkinson's disease symptoms for 25 years, but limitations have led researchers to look for ways to improve the technique.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wayne Fleischhacker, DO Po Box 415750, Boston, MA 02241-5750 Ph: (908) 851-8602 | Wayne Fleischhacker, DO 695 Chestnut Street, Union, NJ 07083 Ph: (908) 851-8602 |
News Archive
All humans are 99.9 percent identical, genetically speaking. But that tiny 0.1 percent variation has big consequences, influencing the color of your eyes, the span of your hips, your risk of getting sick and in some ways even your earning potential.
With an estimated four to six percent of children in the U.S. suffering from food allergies, a new study shows that pediatricians and family physicians aren't always confident they have the ability to diagnose or treat food allergies.
A new study published in the July 11 issue of the Journal of Neuroscience details the development of the first mouse model engineered to carry the most common mutation in Usher syndrome III causative gene (Clarin-1) in North America.
Mazor Robotics Ltd., a leading developer of innovative bone mounted surgical robotic guidance systems, today entered into two strategic agreements with Medtronic plc (NYSE: MDT). One agreement is a two-stage, multi-faceted, commercial agreement for co-promotion, co-development and, upon meeting certain milestones, potential global distribution of certain Mazor products. The second agreement is for an equity investment by Medtronic in Mazor.
Deep brain stimulation has been used to treat Parkinson's disease symptoms for 25 years, but limitations have led researchers to look for ways to improve the technique.
› Verified 5 days ago
Michael Wilcenski, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 695 Chestnut Street, Union, NJ 07083 Phone: 908-851-8602 Fax: 908-851-8758 | |
Edward Novik, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 695 Chestnut Street, Union, NJ 07083 Phone: 908-851-8602 Fax: 908-851-8758 | |
Dr. Lakshmi Garipalli, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1201 Morris Ave, Union, NJ 07083 Phone: 908-688-3727 Fax: 908-688-3036 | |
Randolph Kahn, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 695 Chestnut St, Union, NJ 07083 Phone: 908-851-7161 | |
Dr. Mahboob Hussain, M.D., Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1201 Morris Ave, Union, NJ 07083 Phone: 908-688-3727 Fax: 908-688-3036 | |
Ramesh Shah, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1000 Galloping Hill Rd, Union, NJ 07083 Phone: 908-851-8346 | |
Prafulla Shah, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1000 Galloping Hill Rd, Union, NJ 07083 Phone: 908-851-7161 |